CELYAD ONCOLOGY SA Impairment Loss
CELYAD ONCOLOGY SA reported Impairment Loss of EUR 0 for the 6-month period ending 2022-06-30, per its 6-K filed 2022-08-05.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLoss · last filed 2023-03-23
| Period end | Impairment Loss 6 month | Impairment Loss 12 month | Impairment Loss 12 month as first filed |
|---|---|---|---|
| 2022-06-30 | 0.00 EUR 6-K · filed 2022-08-05 | ||
| 2021-12-31 | 0.00 EUR 20-F · filed 2023-03-23 | 35.70M EUR 20-F · filed 2022-03-24 | |
| 2021-06-30 | 0.00 EUR 6-K · filed 2021-08-04 | ||
| 2020-12-31 | 35.60M EUR 20-F · filed 2021-03-24 | ||
| 2020-06-30 | 0.00 EUR 6-K · filed 2020-08-07 | ||
| 2019-12-31 | 35.50M EUR 20-F · filed 2020-03-25 | ||
| 2019-06-30 | 0.00 EUR 6-K/A · filed 2019-09-05 |